IL-2/CD25: A long-acting fusion protein that promotes immune tolerance by selectively targeting the IL-2R on regulatory T cells

Low-dose IL-2 represents an immunotherapy to selectively expand regulatory T cells (Tregs) to promote tolerance in patients with autoimmunity. Here we show that a fusion protein (FP) of mouse IL-2 and mouse IL-2Rα (CD25), joined by a non-cleavable linker, has greater in vivo efficacy than recombinan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Immunol
Autores principales: Ward, Natasha C., Yu, Aixin, Moro, Alejandro, Ban, Yuguang, Chen, Xi, Hsiung, Sunnie, Keegan, James, Arbanas, Jaren M., Loubeau, Martine, Thankappan, Anil, Yamniuk, Aaron P., Davis, Jonathan H., Struthers, Mary, Malek, Thomas R.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6200646/
https://ncbi.nlm.nih.gov/pubmed/30282751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1800907
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares